GENEVA, March 4 -- HOTH THERAPEUTICS, INC. (590 Madison Avenue21st FloorNew York, New York 10022) filed a patent application (PCT/US2025/042783) for "TOPICAL APREPITANT FORMULATION" on Aug 20, 2025. With publication no. WO/2026/043989, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KNIE, Robb (c/o HOTH THERAPEUTICS, INC.590 Madison Avenue21st FloorNew York, New York 10022)

Abstract: Topical aprepitant formulations and methods of treating epidermal growth factor receptor inhibitor-associated skin toxicities. In some embo...